Economic TimesDurata Therapeutics’ Dalvance injection gets FDA approvalPharmaceutical Business ReviewDurata Therapeutics has received approval from the US Food and Drug Administration (FDA) for its Dalvance (dalbavancin) injection to treat adult patients with acute bacterial skin and skin structure infections (ABSSSI) caused by susceptible Gram-positive …FDA Approves Durata Drug to Treat Acute Skin InfectionsPhilly Sports ReportFDA OK’s new skin infection treatment by DurataMedCity NewsAntibacterial Drug, Dalvance, Gets FDA Approval To Treat Skin Infections …Medical DailyThe Westside Story -Northern Voices Online -YottaFireall 84 news articles …Read Full Story
Durata Therapeutics' Dalvance injection gets FDA approval - Pharmaceutical Business Review
Real Estate of Cebu
